Skip to main content

Peer Review reports

From: Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study

Original Submission
27 Apr 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 May 2021 Reviewed Reviewer Report
4 Jun 2021 Reviewed Reviewer Report
4 Jun 2021 Reviewed Reviewer Report - Francesco Facchinetti
10 Jun 2021 Author responded Author comments - Anwen Liu
Resubmission - Version 3
10 Jun 2021 Submitted Manuscript version 3
21 Jun 2021 Reviewed Reviewer Report - Francesco Facchinetti
21 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Jul 2021 Editorially accepted
30 Jul 2021 Article published 10.1186/s12885-021-08581-2

You can find further information about peer review here.

Back to article page